Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 62553 

deainfo.nci.nih.gov/advisory/bsc.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 5, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25640 Filed 10–8–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel, November 3, 2010, 2 

p.m. to November 3, 2010, 5 p.m., 

National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892 

which was published in the Federal 

Register on August 30, 2010, 75 FR 

DOC. 2010–21663. 

Date and time was changed from 11/ 

3/2010; 2 p.m. to 5 p.m. to reflect 11/ 

10/2010; 10 a.m. to 1 p.m. The meeting 

is closed to the public. 

Dated: October 5, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25639 Filed 10–8–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Partnership for 

Development of New Therapeutics Classes 

for Select Viral and Bacterial Pathogens. 

Date: October 26, 2010. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Room 3144, Bethesda, MD 

20817 (Telephone Conference Call). 

Contact Person: Frank S. De Silva, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, 301–594–1009, 

fdesilva@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 5, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25617 Filed 10–8–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel, Secondary Data Analysis 

R03s: Special Emphasis Panel. 

Date: October 27, 2010. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Jayalakshmi Raman, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute of Dental and 

Craniofacial Research, One Democracy Plaza, 

Room 670, Bethesda, MD 20892–4878, 301– 

594–2904, ramanj@mail.nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel, Special Emphasis Panel: 

Secondary Data Analysis R03s. 

Date: October 29, 2010. 

Time: 1:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Jayalakshmi Raman, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute of Dental and 

Craniofacial Research, One Democracy Plaza, 

Room 670, Bethesda, MD 20892–4878, 301– 

594–2904, ramanj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: October 5, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25614 Filed 10–8–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 75 FR 59277–59278, 

dated September 25, 2010) is amended 

to reflect the reorganization of the 

National Center for Environmental 

Health, Office of Noncommunicable 

Diseases, Injury and Environmental 

Health, Centers for Disease Control and 

Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: After the title and functional 

statement for the Office of the Director 

(CUG1), National Center for 


srobinson on DSKHWCL6B1PROD with NOTICES
62554 Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 

Environmental Health (CUG), insert the 

following: 

Office of Communication (CUG12). 

The Office of Communication (OC): (1) 

Serves as the principal advisor to the 

center director and divisions on 

communication and marketing science, 

research, practice, and public affairs; (2) 

leads center strategic planning for 

communication and marketing science 

and public affairs programs and 

projects; (3) analyzes context, situation, 

and environment to inform center-wide 

communication and marketing programs 

and projects; (4) ensures use of 

scientifically sound research for 

marketing and communication programs 

and projects; (5) ensures accurate, 

accessible, timely, and effective 

translation of science for use by 

multiple audiences; (6) leads 

identification and implementation of 

information dissemination channels; (7) 

provides communication and marketing 

project management expertise; (8) 

collaborates with external organizations 

and the news, public service, and 

entertainment and other media to 

ensure that scientific findings and their 

implications for public health reach the 

intended audiences; (9) collaborates 

closely with divisions to produce 

materials tailored to meet the 

requirements of news and other media 

channels, including press releases, 

letters to the editor, public service 

announcements, television 

programming, video news releases, and 

other electronic and printed materials; 

(10) coordinates the development and 

maintenance of accessible public 

information through the Internet, social 

media and other applicable channels; 

(11) provides training and technical 

assistance in the areas of health 

communication, risk communication, 

social marketing, and public affairs; (12) 

manages or coordinates communication 

services such as broadcast, graphics, 

photography, writing, and editing; (13) 

provides editorial services, including 

writing, editing, and technical editing; 

(14) facilitates internal communication 

to center staff and allied audiences; (15) 

supervises and manages OC activities, 

programs, and staff; (16) serves as 

liaison to internal and external groups 

to advance the center’s mission; (17) 

collaborates with the CDC Office of the 

Associate Director for Communication 

on media relations, electronic 

communication, health media 

production, and brand management 

activities; (18) collaborates with the 

Office of Public Health Preparedness 

and Response and other NCEH/ATSDR 

entities to fulfill communication 

responsibilities in emergency response 

situations; (19) collaborates with other 

CDC Centers/Institute/Offices in the 

development of marketing 

communications targeted to populations 

that would benefit from a crossfunctional approach; and (20) ensures 

NCEH/ATSDR materials meet CDC and 

Department of Health and Human 

Services standards. 

Dated: September 27, 2010. 

William P. Nichols, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2010–25223 Filed 10–8–10; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 75 FR 59277–59278, 

dated September 25, 2010) is amended 

to reflect the reorganization of the 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention, 

Office of Infectious Diseases, Centers for 

Disease Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the function 

statements for the National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 

Prevention (CJV) and the Office of the 

Director (CJV1) and insert the following: 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention 

(CJV). The National Center for HIV/ 

AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP) maximizes 

public health and safety nationally and 

internationally through the elimination, 

prevention, and control of disease, 

disability, and death caused by Human 

Immunodeficiency Virus Infection/ 

Acquired Immunodeficiency Syndrome 

(HIV/AIDS), non-HIV retroviruses, viral 

hepatitis, other sexually transmitted 

diseases (STDs), and tuberculosis (TB). 

In carrying out its mission, NCHHSTP: 

(1) Builds capacity and enhances public 

health infrastructure for preventing and 

treating HIV/AIDS, viral hepatitis, STDs, 

and TB; (2) coordinates activities and 

programs across CDC and with other 

Department of Health and Human 

Services Operational Divisions in order 

to maximize the public health impact of 

HIV/AIDS, viral hepatitis, STDs, and TB 

interventions; (3) conducts surveillance 

and research to determine the 

distribution, determinants, and burden 

of HIV/AIDS, viral hepatitis, STDs, and 

TB; (4) conducts program evaluation to 

improve programs and activities relating 

to the prevention of HIV/AIDS, viral 

hepatitis, STDs, and TB, and determine 

their impact; (5) provides reference 

laboratory and clinical diagnostic 

services for HIV/AIDS, viral hepatitis, 

STDs, and TB to relevant stakeholders; 

(6) promotes collaboration and service 

integration among HIV/AIDS, viral 

hepatitis, STDs, and TB programs; (7) 

engages external partners to develop 

and implement effective HIV/AIDS, 

viral hepatitis, STDs, and TB policies, 

research, and programs; (8) engages 

partners, to promote health equity and 

reduce health disparities among those 

affected by HIV/AIDS, viral hepatitis, 

STDs, and TB; (9) provides technical 

assistance and training in the diagnosis, 

treatment, and prevention of HIV/AIDS, 

viral hepatitis, STDs, and TB; (10) 

conducts public health communication 

activities to disseminate research 

findings and increase awareness of HIV/ 

AIDS, viral hepatitis, STDs, and TB; (11) 

conducts operational, behavioral, and 

biomedical research to improve the 

distribution, diagnosis, prevention, and 

control of HIV/AIDS, viral hepatitis, 

STDs, and TB; (12) provides scientific 

leadership regarding public health 

ethics and protection of human subjects 

linked to HIV/AIDS, viral hepatitis, 

STDs, and TB; (13) translates research 

findings into public health practice and 

policy for HIV/AIDS, viral hepatitis, 

STDs, and TB prevention; (14) plans, 

coordinates, and guides programs and 

activities with external partners, federal 

agencies, and other organizations 

related to HIV/AIDS, viral hepatitis, 

STDs, and TB prevention, care, and 

treatment; (15) leads and participates in 

the development, implementation, and 

evaluation of policies and guidelines 

related to HIV/AIDS, viral hepatitis, 

STDs, and TB; (16) provides scientific 

leadership regarding screening, 

treatment, immunization, and other 

prevention interventions relevant to 

HIV/AIDS, viral hepatitis, STDs, and 

TB; (17) assures all public health 

decisions are based on the highest 

quality scientific data, openly and 

objectively derived; (18) provides 

leadership to assist international 

partners in establishing and 

maintaining, HIV/AIDS, viral hepatitis, 

STDs, and TB screening, treatment, 


srobinson on DSKHWCL6B1PROD with NOTICES